Takara Bio Inc. (FRA:TF2)

Takara Bio Statistics

Total Valuation

Takara Bio has a market cap or net worth of EUR 757.38 million. The enterprise value is 705.04 million.

Market Cap	757.38M
Enterprise Value	705.04M

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Current Share Class	120.42M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	44.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.16
PB Ratio	1.38
P/TBV Ratio	1.81
P/FCF Ratio	n/a
P/OCF Ratio	32.99
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.33, with an EV/FCF ratio of -15.48.

EV / Earnings	-18.03
EV / Sales	2.91
EV / EBITDA	32.33
EV / EBIT	n/a
EV / FCF	-15.48

Financial Position

The company has a current ratio of 5.47, with a Debt / Equity ratio of 0.10.

Current Ratio	5.47
Quick Ratio	3.58
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	-1.19
Interest Coverage	-2.66

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-1.24%
Return on Capital Employed (ROCE)	-0.92%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	134,809
Profits Per Employee	-21,985
Employee Count	1,779
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Takara Bio has paid 8.44 million in taxes.

Income Tax	8.44M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.08% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+13.08%
50-Day Moving Average	4.27
200-Day Moving Average	4.61
Relative Strength Index (RSI)	77.75
Average Volume (20 Days)	126

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Takara Bio had revenue of EUR 239.83 million and -39.11 million in losses. Loss per share was -0.32.

Revenue	239.83M
Gross Profit	129.49M
Operating Income	-6.14M
Pretax Income	-30.42M
Net Income	-39.11M
EBITDA	21.62M
EBIT	-6.14M
Loss Per Share	-0.32

Balance Sheet

The company has 107.73 million in cash and 54.32 million in debt, with a net cash position of 53.41 million.

Cash & Cash Equivalents	107.73M
Total Debt	54.32M
Net Cash	53.41M
Net Cash Per Share	n/a
Equity (Book Value)	550.42M
Book Value Per Share	4.56
Working Capital	189.85M

Cash Flow

In the last 12 months, operating cash flow was 22.96 million and capital expenditures -68.50 million, giving a free cash flow of -45.54 million.

Operating Cash Flow	22.96M
Capital Expenditures	-68.50M
Free Cash Flow	-45.54M
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-2.56%
Pretax Margin	-12.68%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 1.72%.

Dividend Per Share	0.10
Dividend Yield	1.72%
Dividend Growth (YoY)	0.51%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	1.72%
Earnings Yield	-5.16%
FCF Yield	-6.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 29, 2011. It was a forward split with a ratio of 400.

Last Split Date	Mar 29, 2011
Split Type	Forward
Split Ratio	400

Scores

Altman Z-Score	n/a
Piotroski F-Score	2